切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Synthases/Synthetases - Topoisomerases - Progesterone Receptors - Thymidylate Synthase

27件产品中的 11-20

页面
每页
清除全部
  1. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  2. Mifepristone
    B1511 Mifepristone
     3 Citation
    中文名: 美服培酮
    Target: Progesterone Receptors|Glucocorticoid Receptors
    Summary: 孕激素受体拮抗剂
      ≥21.48 mg/mL
      insoluble in H2O
  3. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  4. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  5. Ofloxacin
    A5511 Ofloxacin
    中文名: 氧氟沙星
    Target: Topoisomerases|DNA gyrase
    Summary: 氟喹诺酮类抗生素
      ≥12.03 mg/mL
      insoluble in H2O
  6. Oligomycin A
    A5588 Oligomycin A
     1 Citation
    中文名: 寡霉素A
    Target: Synthases/Synthetases
    Summary: 线粒体ATP合成酶抑制剂
      ≥9.89 mg/mL
      insoluble in H2O
  7. Dexrazoxane HCl (ICRF-187, ADR-529)
    A1602 Dexrazoxane HCl (ICRF-187, ADR-529)
    中文名: 右雷佐生盐酸盐
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,细胞内离子螯合剂,心脏保护剂
      ≥15.24 mg/mL
      ≥16 mg/mL
  8. Epirubicin HCl
    A2451 Epirubicin HCl
    中文名: 盐酸表阿霉素
    Target: Topoisomerases
    Summary: 抗生素类抗肿瘤药物
      ≥29.00 mg/mL
      ≥40.33 mg/mL
  9. Etoposide
    A1971 Etoposide
     4 Citation
    中文名: 依托泊苷
    Target: Topoisomerases
    Summary: 拓扑异构酶II(Topo II)抑制剂
      ≥29.45 mg/mL
      insoluble in H2O
  10. Camptothecin
    A2877 Camptothecin
     1 Citation
    中文名: 喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥8.7 mg/mL
      insoluble in H2O

27件产品中的 11-20

页面
每页